Contract Orientation and Kickoff Meeting

NIH RePORTER · NIH · N01 · $3,500 · view on reporter.nih.gov ↗

Abstract

The objective of the “Preclinical PREVENT Cancer Program: Toxicology and Pharmacology Testing” IDIQ contracts will be to continue evaluation of the pharmacological and toxicological effects of potential cancer preventative agents. Resources from these contracts will be used to support development of several candidate cancer preventive agents.

Key facts

NIH application ID: 11032070
Project number: 75N91024D00002-0-759102400001-1
Recipient: UNIVERSITY OF ILLINOIS AT CHICAGO
Principal Investigator: ALEXANDER V LYUBIMOV
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $3,500
Award type: —
Project period: 2024-01-25 → 2029-02-24